Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCleantech Lithium Regulatory News (CTL)

If you are a professional, HNW or sophisticated investor and want to learn more about the current investment opportunity in Peloton Minerals, please submit your details here.

Share Price Information for Cleantech Lithium (CTL)

Share Price is delayed by 15 minutes
Get Live Data
6.35    0.25 (4.10%)
Bid:
6.20
Ask:
6.50
Spread: 0.30 (4.839%)
Market Cap: £19.56m
CTL Live PriceLast checked at - London Stock Exchange

Intraday Cleantech Lithium Share Chart

Total Voting Rights

1 Dec 2022 14:08

RNS Number : 3107I
CleanTech Lithium PLC
01 December 2022
 

1 December 2022

 

CleanTech Lithium PLC ("CleanTech Lithium" or the "Company")

Total Voting Rights

 

CleanTech Lithium PLC (AIM: CTL, Frankfurt: T2N), an exploration and development company, advancing the next generation of sustainable lithium projects in Chile, in conformity with the Disclosure Guidance and Transparency Rules ("DTRs") of the Financial Conduct Authority ("FCA"), announces:

 

As at the date of this announcement the Company's issued share capital consists of 105,333,500 ordinary shares of 1p each (the "Ordinary Shares") with voting rights. The Company does not hold any Ordinary Shares in treasury.

 

Accordingly, the above figure of 105,333,500 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's DTRs.

 

For further information visit www.ctlithium.com or contact the following:

 

 

CleanTech Lithium PLC

 

Aldo Boitano

Gordon Stein

Jersey office: +44 (0) 1534 668 321

Chile office: +562-32239222

Or via Celicourt

 

Beaumont Cornish Limited

(Nominated Adviser)

Roland Cornish

 

+44 (0) 207 628 3396

Fox-Davies Capital Limited

(Joint Broker)

Daniel Fox-Davies

 

+44 (0) 20 3884 8450

 

daniel@fox-davies.com

 

Canaccord Genuity Limited

(Joint Broker)

James Asensio

Gordon Hamilton

 

+44 (0) 207 523 4680

 

 

Celicourt Communications

Felicity Winkles/Philip Dennis

 

+44 (0) 20 8434 2754

ctl@celicourt.uk

Dr. Reuter Investor Relations

Dr. Eva Reuter

+49 69 1532 5857

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRGZMGZDMRGZZM
Date   Source Headline
30th Jun 20257:00 amRNSExtension to Loan Notes Maturity Date
12th Jun 202511:00 amRNSFinal Results
30th Apr 20257:00 amRNSUpdate to CEOL Application
23rd Apr 20257:00 amRNSUpdate to CEOL Process
17th Apr 20257:00 amRNS-RCollaboration with DuPont Water Solutions
10th Apr 20257:00 amRNSAppointment of CEO and Director
4th Apr 20257:00 amRNSCEOL Application Process Update
24th Mar 202512:47 pmRNSResult of GM Admission of Retail Offer Shares TVR
10th Mar 20257:00 amRNSResults of Retail Offer & Update on Broker Option
4th Mar 20254:45 pmRNSNotice of General Meeting and Posting of Circular
28th Feb 20256:17 pmRNSTotal Voting Rights
26th Feb 20257:00 amRNSASX Listing and CEO Designate
21st Feb 20257:00 amRNSExtension of Broker Option and Retail Offer
18th Feb 20257:00 amRNS-RInvestor Meet Company Spotlight Event
17th Feb 20257:00 amRNSRetail Offer to Shareholders
11th Feb 20257:28 amRNSResults of Placing, Issue of Equity and TVR
10th Feb 20254:52 pmRNSProposed interim fundraising and corporate update
20th Jan 20257:00 amRNSLaguna Verde Resource Update
15th Jan 20257:00 amRNSApplication for CEOL Submitted
14th Jan 20258:14 amRNSDownstream Process Produces Lithium Carbonate
31st Dec 20247:00 amRNSCEOL application and amended 2024 interim results
6th Dec 20247:00 amRNSIssue of Equity and TVR
28th Nov 20247:00 amRNSCorporate Update & Appointment of CEO Designate
26th Nov 20242:59 pmRNSResult of AGM, Share Consolidation and TVR
25th Nov 20245:35 pmRNSFurther information re share consolidation
21st Nov 20247:00 amRNSPilot-Scale Lithium Carbonate Production
15th Nov 20242:42 pmRNSHolding(s) in Company
5th Nov 20247:00 amRNSLaguna Verde Operational Update
1st Nov 202410:00 amRNSTotal Voting Rights
30th Oct 20241:34 pmRNSNotice of AGM
22nd Oct 20247:00 amRNSUpdate to Laguna Verde Licence Payment Terms
9th Oct 20247:04 amRNSResults of Placing, PDMR Dealing & TVR
8th Oct 20245:03 pmRNSProposed interim fundraising
30th Sep 20247:00 amRNSInterim Results
27th Sep 20247:00 amRNSCEOL Update
20th Sep 20247:00 amRNSUpdate on the ASX Listing
9th Sep 20247:00 amRNSASX-Listing Admission Process Update
2nd Sep 202412:29 pmRNSResults of General Meeting; Update on RFI Process
27th Aug 20244:10 pmRNSTransfer of Loan Notes at Regal Funds
27th Aug 20247:00 amRNSReplacement ASX Prospectus
13th Aug 20247:14 amRNSASX Prospectus, Proposed Fundraise & Notice of GM
22nd Jul 20247:00 amRNSDLE Pilot Plant First Stage Production & Results
2nd Jul 20247:00 amRNSPFS Plant Location Study Results
1st Jul 20247:00 amRNSBridging Loan & Termination Convertible Loan Notes
25th Jun 20247:00 amRNSExpressions of Interest Submitted
29th May 20247:00 amRNSInauguration of DLE Pilot Plant
23rd May 20247:00 amRNSOperations Update
21st May 20247:00 amRNSFinal Results
15th May 20247:00 amRNSInvestor Presentation via Investor Meet Company
14th May 20247:00 amRNSDLE Pilot Plant Produces High Quality Eluate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.